| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3291996 | Gastroenterology | 2016 | 16 Pages |
Abstract
In a clinical trial of patients with diabetic gastroparesis, relamorelin (10 μg twice daily) significantly accelerated gastric emptying and significantly reduced vomiting, compared with placebo. Among patients with baseline vomiting, relamorelin had prokinetic effects and significantly reduced vomiting and also improved other symptoms of diabetic gastroparesis compared with placebo. ClincialTrials.gov number: NCT01571297.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Anthony Lembo, Michael Camilleri, Richard McCallum, Ramon Sastre, Cristian Breton, Sharon Spence, Jeffery White, Michelle Currie, Keith Gottesdiener, Elizabeth Stoner, RM-131-004 Trial Group RM-131-004 Trial Group,